The mission of Columbia University Medical Center’s Clinical and Translational Science Award (CTSA) is to transform the culture of research to hasten the discovery and implementation of new treatments and prevention strategies. Our core objective is to move the CUMC (Columbia University Medical Center) research community to a more multi- and interdisciplinary scientific mindset by removing barriers and creating incentives for interactions among investigators from different disciplines.
CUMC’s first step toward reaching this goal was the establishment of the Irving Institute for Clinical and Translational Research—the academic home for clinical and translational research at Columbia. Irving Institute faculty include some of CUMC’s most accomplished, senior researchers who provide leadership and serve as mentors for junior faculty, fellows, and trainees. The resources provided by the Irving Institute offer support in biomedical informatics, study design and biostatistics, bioethics, regulatory issues, core laboratory facilities, community engagement, plus a fully-staffed Clinical Research Resource for campus investigators.
The Irving Institute comprises 9 key functions, or resources, that are available to the CUMC research community. More details on each of the 9 key functions may be found here.
Additionally, funded through a CTSA supplement, the Comparative-Effectiveness Research (CER) Studio was established to bring together bioinformatics researchers and clinical/health services researchers to enhance the research capacity of our existing data infrastructures. The Studio's "How-to" Guide is now available online and may be a useful resource for conducting comparative-effectiveness research.